Table 1.
Patient | Gender | Age (year) | BLO | PRO | Urea nitrogen (mmol/L) | Inosine (μmol/L) | TP (g/L) | ALB (g/L) | CHOL (mmol/L) | Hearing loss | Vision loss (L/R) |
III2 | Female | 26 | ++ | + | 6.6 | 121 | 57 | 35 | 5.76 | + | 0.2/1.0 |
III3 | Female | 23 | + | + | 3.9 | 110 | 71 | 45 | 4.45 | + | 0.4/1.0 |
II3 | Female | 51 | ++ | ++ | 3.5 | 231 | 70 | 43 | 4.68 | + | 0.2/0.8 |
II1 | Male | 54 | – | – | 3.1 | 46 | 80 | 47 | 3.19 | – | 1.5/1.5 |
II2 | Female | 58 | – | + | 3.5 | 53 | 86 | 48 | 4.02 | – | 1.0/1.0 |
II4 | Male | 53 | – | – | 3.0 | 55 | 75 | 52 | 3.81 | – | 1.0/1.0 |
III1 | Male | 21 | – | – | 3.2 | 56 | 66 | 45 | 4.61 | – | 1.5/1.0 |
III4 | Female | 17 | – | – | 3.2 | 50 | 75 | 43 | 4.98 | – | 1.2/1.1 |
BLO: occult blood; PRO: urinary protein; TP: total protein; ALB: albumin; CHOL: cholesterol; L/R: left/right